Hy-Tech Engineers Ltd
NSE: HTEL · Other Industrial Products · Q1FY27 · standalone figures · Report generated 28 Oct 2026
Price (28 Oct 2026)
FY26 Revenue
YoY
FY26 PAT
YoY
EBITDA Margin
FY25:
MCAP (locked)
as of 28 Oct 2026
Current P/E
FY26 PAT basis
1Y Fwd PEG (Base)
G = 25%
ROE FY26
ROCE FY26
Net D/E
FY25:
💰 Valuation Comfort Panel
G — growth rate basis (Concall PAT guidance): G is the forward rate from management's guidance — explicit PAT growth guidance 25%; 2-year G from the multi-year PAT target ₹500 Cr by 5 years (implied CAGR over 5 years) — not the base-effect YoY PAT growth of 15%.
Current PEG
✗ Above 1.5x — pricing in a lot
PE ÷ PAT growth
1Y Forward PEG (Base 25%)
⚠ 1–1.5x — fair to slightly expensive
1Y Fwd PE ÷ G 25%
MCAP ÷ PAT₁
MCAP ÷ PAT₁
2Y Forward PEG (Base 25%)
✓ Below 1x — growth underpriced
2Y Fwd PE ÷ G 25%
MCAP ÷ PAT₂
MCAP ÷ PAT₂
| Scenario | G | PAT +1Y | 1Y Fwd PE | PAT +2Y | 2Y Fwd PE | 1Y PEG | 2Y PEG | Read |
|---|---|---|---|---|---|---|---|---|
| Bear | 15% | Growth slips to 15% — what the price looks like if guidance is missed. | ||||||
| Base | 25% | Management-guided rate 25% — is it deliverable? | ||||||
| Bull | 35% | Growth reaches 35% — upside if execution beats. |
Required PAT growth for PEG = 1x: . For PEG 1.5x: . Needs 25.7% PAT growth for PEG <1x. Management guided 25%. Gap = 0.7pp.At the current price, the market is pricing in about 25.7% PAT growth (the rate at which 1Y PEG equals 1x). Management's guidance implies 25% in the base case, 0.7pp below that bar. The base-case 1Y forward PEG is 1.03x — fair to slightly expensive. If growth slips to 15%, the 1Y PEG becomes 1.86x.
🧾 Guidance Extraction Block (Step 7A)
Forward-guidance override applied. Current PAT growth 15% — below threshold. Management guided 25%+ for FY+1 due to explicit PAT guidance; explicit revenue guidance; multi-year PAT target; explicit revenue growth 20% (FY27); explicit PAT growth 25% (FY27); explicit revenue growth 20% (next 3 years); capacity addition 100% by next three years. Math check: explicit PAT growth guidance 25% = 25% PAT growth. Override invoked. Track delivery at next concall.
| # | Item | Status | What management said / what was calculated | Value |
|---|---|---|---|---|
| 1 | Explicit PAT/profit guidance | ✓ GIVEN | "PAT will keep on going up by about 25% to 30%" → 25% (FY27)“PAT will keep on going up by about 25% to 30%” | |
| 2 | Explicit revenue guidance | ✓ GIVEN | "top line will grow up by 20%" → 20% (FY27)“top line will grow up by 20%” | |
| 3 | Explicit margin guidance | ✓ GIVEN | "EBITDA margin will be maintained at about 24% to 25%" → 24% (FY27)“EBITDA margin will be maintained at about 24% to 25%” | |
| 4 | Multi-year PAT target | ✓ GIVEN | "Five years down the line, we'll go to 500" → ₹500 Cr (5 years)“Five years down the line, we'll go to 500” | |
| 5 | Seasonality / quarterly signals | NOT GIVEN | NOT GIVEN | |
| 6 | Acceleration / deceleration signal | ✓ GIVEN | accelerating: "we are going to double the turnover in a period of next three years' time"“we are going to double the turnover in a period of next three years' time” | |
| 7 | Historical anchor (annual results filings) | ✓ GIVEN | FY25 Revenue: ₹161 Cr | PAT: ₹20 Cr | PAT margin: 12.4%; FY26 Revenue: ₹189 Cr | PAT: ₹23 Cr | PAT margin: 12.2%; 2-year avg revenue growth: 40.8% | |
| 8 | MCAP locked | ✓ GIVEN | ₹738 Cr (source: Screener (price and market cap), date: 2026-10-28T08:58:33.790Z) |
Earnings pace: PASS OVERRIDE — current PAT growth , guided . Current PAT growth 15% is below 20%, but the forward-guidance override applies (explicit PAT growth guidance 25% = 25% PAT growth). Conditional pass — verify at the next concall.
📊 Financial Statement Analysis — FY22 to FY26 (5-Year Deep Dive)
✓ FINANCIALLY SOUND
2 pass, 0 caution, 0 fail, 6 not assessed (data gap).
FSA-1
Balance Sheet Strength
– DATA GAP
FSA-2
Leverage Ratios
– DATA GAP
FSA-3
Cash Flow Quality
– DATA GAP
FSA-4
Self-Funded Growth
– DATA GAP
FSA-5
Revenue & Profit Growth
✓ ACCELERATING
FSA-6
Earnings Quality CFO/PAT
– DATA GAP
FSA-7
Profitability ROE/ROCE
– DATA GAP
FSA-8
Margin Sustainability
✓ 22.8% STABLE
FSA-1 · Balance Sheet Strength
| Year | Equity | Borrowings | Net D/E | WC Days | CWIP / Net Block | Goodwill / Equity |
|---|---|---|---|---|---|---|
| FY22 | ||||||
| FY23 | ||||||
| FY24 | ||||||
| FY25 | ||||||
| FY26 |
FSA-1 verdict: – DATA GAP. Equity, net D/E and working-capital days are missing for the last two years. FY26 equity: FY26 net D/E: FY26 working capital days:
FSA-2 · Leverage & Interest Coverage
| Year | Net D/E | CFO / EBITDA | Interest Coverage |
|---|---|---|---|
| FY22 | |||
| FY23 | |||
| FY24 | |||
| FY25 | |||
| FY26 | |||
| Aeroflex Industries Ltd (FY26) | |||
| Yuken India Ltd (FY26) |
FSA-2 verdict: – DATA GAP. Net debt / equity is missing. FY25 net D/E: FY26 net D/E: FY26 interest coverage:
FSA-3 + FSA-4 · Cash Flow Quality & Self-Funded Growth
| Year | CFO | CFI | CFF | Capex | FCF | FCF Margin |
|---|---|---|---|---|---|---|
| FY22 | ||||||
| FY23 | ||||||
| FY24 | ||||||
| FY25 | ||||||
| FY26 |
FSA-3 verdict: – DATA GAP. Fewer than two years of operating cash flow.
FSA-4 verdict: – DATA GAP. Free cash flow (CFO − capex) is missing. FY26 FCF (CFO − capex):
Data table: Cash flow history FY22 to FY26: CFO, CFI, FCF
| Series | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| CFO (₹ Cr) | |||||
| CFI (₹ Cr) | |||||
| FCF (₹ Cr) |
FSA-5 · Revenue & Profit Growth
| Year | Revenue | Rev Growth | EBITDA | EBITDA Growth | PAT | PAT Growth |
|---|---|---|---|---|---|---|
| FY22 | ||||||
| FY23 | ||||||
| FY24 | ||||||
| FY25 | ||||||
| FY26 | ||||||
| Aeroflex Industries Ltd (FY26) | ||||||
| Yuken India Ltd (FY26) |
| 2-Year CAGR | Revenue | EBITDA | PAT |
|---|---|---|---|
| Hy-Tech Engineers Ltd | |||
| Aeroflex Industries Ltd | |||
| Yuken India Ltd |
FSA-5 verdict: ✓ ACCELERATING. Revenue growth 16.7% → 17.4%; PAT growth 15%. FY26 revenue growth: FY26 PAT growth: FY25 revenue growth:
FSA-6 · Earnings Quality — CFO vs PAT
| Year | PAT | CFO | CFO / PAT |
|---|---|---|---|
| FY22 | |||
| FY23 | |||
| FY24 | |||
| FY25 | |||
| FY26 |
FSA-6 verdict: – DATA GAP. CFO/PAT is missing. FY26 CFO/PAT:
Data table: CFO vs PAT FY22 to FY26
| Series | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| PAT (₹ Cr) | |||||
| CFO (₹ Cr) |
FSA-7 · Profitability (ROE / ROCE) with DuPont
| Year | ROE | ROCE | PAT Margin | Asset Turnover | Equity Multiplier |
|---|---|---|---|---|---|
| FY22 | |||||
| FY23 | |||||
| FY24 | |||||
| FY25 | |||||
| FY26 | |||||
| Aeroflex Industries Ltd (FY26) | |||||
| Yuken India Ltd (FY26) |
FSA-7 verdict: – DATA GAP. ROE or ROCE is missing. ROE: ROCE:
FSA-8 · Margin Sustainability
| Year | EBITDA Margin | PAT Margin |
|---|---|---|
| FY22 | ||
| FY23 | ||
| FY24 | ||
| FY25 | ||
| FY26 | ||
| Aeroflex Industries Ltd (FY26) | ||
| Yuken India Ltd (FY26) |
| Company | EBITDA Margin (prior FY) | EBITDA Margin (latest FY) | Change (pp) | Trend | Margin guidance (latest concall) |
|---|---|---|---|---|---|
| Hy-Tech Engineers Ltd | FY25 | FY26 | Stable | Margin 24% (FY27) | |
| Aeroflex Industries Ltd | FY25 | FY26 | Expanding | No margin guidance | |
| Yuken India Ltd | FY25 | FY26 | Contracting | No margin guidance |
FSA-8 verdict: ✓ 22.8% STABLE. EBITDA margin 22.4% → 22.8% (+0.4pp) — held or expanded. Latest quarter Q1FY27: 19.6%. FY26 EBITDA margin: FY25 EBITDA margin: Q1FY27 EBITDA margin:
🔬 Marcellus 3-Level Forensic Accounting Check
✓ FORENSIC CLEAN
Level 1: 0 flags, 12 data gaps. Level 2: no governance findings with quotes. Level 3: 1 corroborating, 0 to investigate.
Level 1 · Quantitative Ratio Checks
L1-1
CFO/PAT (FY26)
– Data gap — CFO/PAT
L1-2
CFO/EBITDA (FY26)
– Data gap — CFO/EBITDA
L1-3
CFO multi-year volatility
– Data gap — at least 3 years of operating cash flow
L1-4
Yield on cash
– Data gap — other income and two years of cash balances
L1-5
Goodwill / net worth
– Data gap — goodwill to equity
L1-6
R&D: capitalised?
– Data gap — the annual report's R&D accounting
L1-7
CWIP / net block
– Data gap — CWIP and net block
L1-8
FCF / revenue
– Data gap — free cash flow margin
L1-9
DuPont (ROE drivers)
– Data gap — PAT margin, asset turnover and equity multiplier for two years
L1-10
Auditor changes
– Data gap — the annual report's auditor details
L1-11
Adverse auditor comment
– Data gap — the annual report's audit opinion
L1-12
Contingent liabilities / net worth
– Data gap — Annual Report
L1-1 CFO/PAT (FY26): Not assessed: CFO/PAT is not available. L1-2 CFO/EBITDA (FY26): Not assessed: CFO/EBITDA is not available. L1-3 CFO multi-year volatility: Not assessed: at least 3 years of operating cash flow is not available. L1-4 Yield on cash: Not assessed: other income and two years of cash balances is not available. L1-5 Goodwill / net worth: Not assessed: goodwill to equity is not available. L1-6 R&D: capitalised?: Not assessed: the annual report's R&D accounting is not available. L1-7 CWIP / net block: Not assessed: CWIP and net block is not available. L1-8 FCF / revenue: Not assessed: free cash flow margin is not available. L1-9 DuPont (ROE drivers): Not assessed: PAT margin, asset turnover and equity multiplier for two years is not available. L1-10 Auditor changes: Not assessed: the annual report's auditor details is not available. L1-11 Adverse auditor comment: Not assessed: the annual report's audit opinion is not available. L1-12 Contingent liabilities / net worth: Contingent liabilities are not available from the annual report.
Level 2 · Corporate Governance Checks
No Level 2 findings could be supported by a filing quote.
Level 3 · Primary Data Corroboration
✓ Corroborates
Marquee CustomersCorroborates
Management names Tata Hitachi, Sany, and Fluidconnecto as new OEM clients, validating business traction.
“New OEMs which are now we got in bauma are Tata Hitachi, it's a major OEM, and then Sany, a Chinese manufacturer, and then there was one more, is Fluidconnecto. He is also in India in Bangalore, but they have a plant in Italy, so they are also very keen. So, that way, the amount of business that we are likely to get, and it is in the pipeline, is quite a lot” “Now, they are the leading manufacturers of excavators in India. Probably, they are selling something like 600 excavators a month. But their entire fittings are being imported from China. Now, they have a commitment to the government to indigenize. So, there is a time period of 3 years. Now, that is over. Now, last month, Sany director had visited us, and they said, baba, we have got a tremendous requirement of these fittings. Can you do it, and we have to import-substitute this?” 📊 Market Share — Subject vs Peers
| Company | Sales Growth (FY) | PAT Growth (FY) | EBITDA Margin (FY) | EBITDA Margin Change vs Prior FY (pp) | PAT Margin (FY) | ROE | Sales Growth (Latest Q YoY) | PAT Growth (Latest Q YoY) | Management Guidance (latest concall) | vs Hy-Tech |
|---|---|---|---|---|---|---|---|---|---|---|
| 🏆 Hy-Tech Engineers Ltd | Stable |
| — | |||||||
| Aeroflex Industries Ltd | Expanding | No guidance given (or no concall transcript filed) | Hy-Tech growing PAT 2.6× faster | |||||||
| Yuken India Ltd | Contracting | No guidance given (or no concall transcript filed) | Hy-Tech growing PAT 53.7pp faster | |||||||
| Only 2 direct listed competitors found in India for this business; candidates that are not direct competitors are listed below. | ||||||||||
Peer list source: Tijori Finance competitor list and Screener industry peers. Peer figures come from each peer's own exchange filings; guidance is quoted from each company's latest earnings call. Peers not used: Dynamatic Tech., HBL Engineering (same industry list, but not confirmed as a direct competitor), Inox India (same industry list, but not confirmed as a direct competitor), Esab India (same industry list, but not confirmed as a direct competitor).
📋 7-Step Investment Checklist
5/9
5 of 9 criteria passed (7 steps + ROE + ROCE)
Hard rules: 1 failed.
Hard rules: 1 failed.
Hard rules
✓ PASS
PAT growth ≥ 20%OVERRIDE
Current PAT growth 15% — below threshold. Management guided 25%+ for FY+1 due to explicit PAT guidance; explicit revenue guidance; multi-year PAT target; explicit revenue growth 20% (FY27); explicit PAT growth 25% (FY27); explicit revenue growth 20% (next 3 years); capacity addition 100% by next three years. Math check: explicit PAT growth guidance 25% = 25% PAT growth. Override invoked. Track delivery at next concall.
Latest FY PAT growth: Guided PAT growth (component math): “PAT will keep on going up by about 25% to 30%” “top line will grow up by 20%” “Five years down the line, we'll go to 500” “top line will grow up by 20%” “PAT will keep on going up by about 25% to 30%” “we expect a minimum of 20% growth this year and maybe a little more than that in the further two years” “Today, we are manufacturing around 35 lakhs of fittings every month, and the proceeds that we have got now from IPO, we are going to go to 70 lakhs per month” “PAT will keep on going up by about 25% to 30%” ✓ PASS
Earnings growth vs fastest peer (R11)LEADS PEERS
Fastest peer Aeroflex Industries Ltd grew FY PAT 5.8%; subject 15% — 9.2pp ahead (allowed: within 5pp).
Subject FY PAT growth: Aeroflex Industries Ltd FY PAT growth (fastest peer): ✓ PASS
Revenue growth (R12)PASS 17.4%
Revenue growth 17.4%.
Latest FY revenue growth: ✗ FAIL
Sunrise / sunset sector (R13)SUNSET
peer median FY PAT growth -16.5% (fast if ≥ 15%); peer concall tone not assessed.
Peer median FY PAT growth: NOT ASSESSED
ROEMISSING
ROE for the latest FY is missing (FY25 balance sheet).
NOT ASSESSED
ROCEMISSING
ROCE for the latest FY is missing (FY25 balance sheet).
Checklist steps
✓ PASS
Business model understandabilityPASS — SIMPLE
Hy-Tech's business model revolves around manufacturing hydraulic fittings, clearly explained through discussions on capacity expansion, export targets, and OEM partnerships.
“The US business we started somewhere in 2012, and now, we have touched almost about 25% of our business is going to USA. And around 7% to 8% to Europe, and there is a tremendous amount of scope for increasing this business, especially in Europe, because Europe, there are no tariff restrictions like what we have in USA because of today's President.” “Recently, we have participated in bauma, and the response was tremendous. Few OEMs who are not working with us, they are also very keen to now start working with us. So, even domestic business also I'm expecting a growth of about 15% to 20%.” “There is no person from China here. In fact, Chinese manufacturers -- equipment manufacturers, are also buying fittings from us.” “As far as domestic competition is there, now, as I told you in my speech, my second competitor, domestic competitor, is less than half the turnover what Hy-Tech has got.” “Today, we are manufacturing around 35 lakhs of fittings every month, and the proceeds that we have got now from IPO, we are going to go to 70 lakhs per month. We are going to double the turnover in a period of next three years' time.” “The total requirement of this fittings all over the world is 40,000 crores. Out of that, 20,000 crores fittings are consumed in USA, 10,000 crores of fittings are consumed in Europe, and around 2,000 crores are consumed in India. So, we are at about 10% of Indian market, and balance 8,000 are spread over other countries.” ✗ FAIL
Sunrise or sunset sectorSUNSET
peer median FY PAT growth -16.5% (fast if ≥ 15%); peer concall tone not assessed.
Peer median FY PAT growth: ⚠ CAUTION
Market share momentumHOLDING
Subject FY revenue growth 17.4% vs peers 17.5%, 1.1%; faster than 1 of 2.
Subject FY revenue growth: ✓ PASS
Future visibility of earnings growth (pace)PASS OVERRIDE
Current PAT growth 15% is below 20%, but the forward-guidance override applies (explicit PAT growth guidance 25% = 25% PAT growth). Conditional pass — verify at the next concall.
Current FY PAT growth: Guided PAT growth: “PAT will keep on going up by about 25% to 30%” NOT ASSESSED
Normalise one-off effectsNOT ASSESSED
Not assessed — no judgment with a supporting quote.
⚠ CAUTION
Volume vs value decompositionMIXED
Growth is driven by both volume expansion (doubling monthly fittings production) and value (price revisions from OEMs).
“And that price revision we got it effective 1st of April, but we will be getting it in the second quarter. So, that profit, which is now lying with OEM, they will transfer it to us, and that will come in the second quarter.” “Today, we are manufacturing around 35 lakhs of fittings every month, and the proceeds that we have got now from IPO, we are going to go to 70 lakhs per month. We are going to double the turnover in a period of next three years' time.” ✓ PASS
New capacity vs same-base growthBOTH GROWING
Growth comes from new capacity (IPO-funded expansion to 70 lakh fittings/month) and utilization of existing infrastructure (35-40% idle capacity).
“Today, we are manufacturing around 35 lakhs of fittings every month, and the proceeds that we have got now from IPO, we are going to go to 70 lakhs per month. We are going to double the turnover in a period of next three years' time.” “Existing plant gives us around 35% to 40% infrastructure available with us, so we can go up to from 200 to 300, there is no problem. We have the infrastructure.” “Today, we are manufacturing around 35 lakhs of fittings every month, and the proceeds that we have got now from IPO, we are going to go to 70 lakhs per month” ✓ PASS
Capex backing the growthPASS — SPECIFIC CAPEX
Capex of ₹30 Cr with a clear one-year timeline is allocated for capacity expansion and automation.
“We have got INR30 crores allotted for capex this year, and we'll be implementing that within a period of one year” ✓ PASS
Operating leveragePASS
EBITDA grew 19.4% vs revenue 17.4% — operating leverage is working.
EBITDA growth: Revenue growth: ✓ PASS
Valuation (forward PEG)1Y PEG 1.03x
Base G 25%: 1Y forward PE 25.7x, 1Y PEG 1.03x. Needs 25.7% PAT growth for PEG <1x. Management guided 25%. Gap = 0.7pp.
1Y Fwd PE (Base): 1Y PEG (Base): Required G for PEG 1x: NOT ASSESSED
ROEMISSING
ROE for the latest FY is missing.
NOT ASSESSED
ROCEMISSING
ROCE for the latest FY is missing.
📈 Pace of Growth
Data table: Revenue, PAT and EBITDA margin FY22 to FY28E (Base 25%)
| Series | FY22 | FY23 | FY24 | FY25 | FY26 | FY27E (Base 25%) | FY28E (Base 25%) |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | |||||||
| PAT (₹ Cr) | |||||||
| EBITDA Margin % |
Estimate columns apply the base-scenario growth rate to the latest PAT; they are calculations, not reported figures.
🎯 Management Guidance Execution Tracker
3 quarters' transcripts not found on NSE (1 of the last 4 used). The tracker and credibility score use only Q1FY27.
QuarterManagement Commitment (Verbatim)MetricTargetActualStatus
Q1FY27“we are going to double the turnover in a period of next three years' time” revenuedouble turnoverNot yet due (FY30)● IN PROGRESS
Q1FY27“we'll be growing at about 20% minimum year-on-year” revenue growth20% minimum year-on-yearNot yet due (FY27)● IN PROGRESS
Q1FY27“bottom line will grow at minimum at 25% to 30%” PAT growth25% to 30%Not yet due (FY27)● IN PROGRESS
Q1FY27“EBITDA margin will be maintained at about 24% to 25%” EBITDA margin24% to 25%Not yet due (FY27)● IN PROGRESS
Q1FY27“in five years, we have decided to go for 50% export and 50% domestic” export share50% exportNot yet due (FY32)● IN PROGRESS
⬜ UNRATED — no scoreable commitments — Score:
0 delivered, 0 missed, 0 partial — nothing scored yetScore = (delivered + 0.5 × partial) ÷ (delivered + missed + partial); 5 still in progress (not scored).Verdict impact: UNRATED — no commitment from the tracked concalls could be scored yet, so there is no execution record. Guidance is used as stated and the verdict is not adjusted for credibility. Only 1 of the last 4 concall transcripts were found on NSE; the tracker uses those 1.
0 delivered, 0 missed, 0 partial — nothing scored yetScore = (delivered + 0.5 × partial) ÷ (delivered + missed + partial); 5 still in progress (not scored).Verdict impact: UNRATED — no commitment from the tracked concalls could be scored yet, so there is no execution record. Guidance is used as stated and the verdict is not adjusted for credibility. Only 1 of the last 4 concall transcripts were found on NSE; the tracker uses those 1.
Management red flags: CFO / PAT ratio — Data gap; Debt trend vs sales — Data gap; Related-party transactions — Data gap; Fraud / criminal cases — NOT ASSESSED
🔍 What To Track
#Management Said (Verbatim)Pass ConditionBy WhenTier
1“we are going to double the turnover in a period of next three years' time” revenue: revenue: double turnover delivered as statedFY30🔴 CRITICAL
2“we'll be growing at about 20% minimum year-on-year” revenue growth: revenue growth ≥ 20%FY27🔴 CRITICAL
3“bottom line will grow at minimum at 25% to 30%” PAT growth: PAT growth within 25%–30%; below 25% = missFY27🔴 CRITICAL
4“EBITDA margin will be maintained at about 24% to 25%” EBITDA margin: EBITDA margin within 24%–25%; below 24% = missFY27🔴 CRITICAL
5“in five years, we have decided to go for 50% export and 50% domestic” export share: export share ≥ 50%FY32🟢 NICE TO HAVE
Management has no scored execution record yet. These are the first checkpoints. At the next concall, check items 1 and 2 first. If both pass, the thesis is intact. If either misses, re-run the full analysis.
📐 ROE / ROCE Trend
NOT ASSESSED
ROEMISSING
ROE for the latest FY is missing.
NOT ASSESSED
ROCEMISSING
ROCE for the latest FY is missing.
Data table: ROE and ROCE FY22 to FY26
| Series | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| ROE % | |||||
| ROCE % |
⚠️ Risk Register
HIGH
Sunrise / sunset sector (R13): SUNSET. peer median FY PAT growth -16.5% (fast if ≥ 15%); peer concall tone not assessed.
HIGH
Sunrise or sunset sector: SUNSET. peer median FY PAT growth -16.5% (fast if ≥ 15%); peer concall tone not assessed.
MED
Market share momentum: HOLDING. Subject FY revenue growth 17.4% vs peers 17.5%, 1.1%; faster than 1 of 2.
MED
Volume vs value decomposition: MIXED. Growth is driven by both volume expansion (doubling monthly fittings production) and value (price revisions from OEMs).“And that price revision we got it effective 1st of April, but we will be getting it in the second quarter. So, that profit, which is now lying with OEM, they will transfer it to us, and that will come in the second quarter.” “Today, we are manufacturing around 35 lakhs of fittings every month, and the proceeds that we have got now from IPO, we are going to go to 70 lakhs per month. We are going to double the turnover in a period of next three years' time.”
📣 Official Updates Since the Latest Results
Material announcements the company filed with the exchange after its latest results, in the company's own words. Checked 28 Oct 2026.
- 23 Oct 2026 · Updates — Hy-Tech Engineers Limited has informed the Exchange regarding 'Receipt of Eligibility Certificate for claiming government subsidy towards a manufacturing plant in Shirwal, Maharashtra'. Open filing ↗
- 7 Oct 2026 · General Updates — Hy-Tech Engineers Limited has informed the Exchange about incorporation of Wholly Owned Subsidiary- HY-TECH ENGINEERS Inc Open filing ↗
- 7 Oct 2026 · Updates — Hy-Tech Engineers Limited has informed the Exchange regarding 'Revised disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.'. Open filing ↗
- 5 Oct 2026 · Updates — Hy-Tech Engineers Limited has informed the Exchange regarding 'Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015'. Open filing ↗
- 29 Sep 2026 · Updates — Hy-Tech Engineers Limited has informed the Exchange regarding disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015. Open filing ↗
- 21 Sep 2026 · Investor Presentation — Hy-Tech Engineers Limited has informed the Exchange about Investor Presentation Open filing ↗
- 21 Sep 2026 · Press Release — Hy-Tech Engineers Limited has informed the Exchange regarding a press release dated September 21, 2026, titled "Press Release for the Unaudited Financial Results for the Quarter ended June 30, 2026.". Open filing ↗
- 18 Sep 2026 · Change in Auditors — Hy-Tech Engineers Limited has informed the Exchange regarding Change in Auditors of the company. Open filing ↗
⚡ One Actionable Takeaway
ELIMINATE: Sunrise / sunset sector (R13): peer median FY PAT growth -16.5% (fast if ≥ 15%); peer concall tone not assessed — move attention to stronger names in the sector.
🕳️ Data Gaps
These inputs were not found in the company's exchange filings, so the sections that need them say so instead of estimating:
- 3 quarters' transcripts not found on NSE (1 of the last 4 used)
- Only 1 of 5 Q4 audited results filings available; annual history covers FY22–FY26
- Only 1 of 8 recent quarters of results available
- Only 1 of 4 recent earnings call transcripts available
- Annual report not available
- Annual P&L (Screener, before NSE filings), 28 Oct 2026 — Open filing ↗
- Earnings Call Transcript, 25 Sep 2026 — Open filing ↗
- Financial Results (official XBRL), 18 Sep 2026 — Open filing ↗
- Financial Results (official XBRL), 11 Aug 2026 — Open filing ↗
- Financial Results (official XBRL), 11 Aug 2026 — Open filing ↗
- Financial Results (official XBRL), 8 Aug 2026 — Open filing ↗
- Financial Results (official XBRL), 3 Aug 2026 — Open filing ↗
- Financial Results (official XBRL), 27 Jul 2026 — Open filing ↗
- Financial Results (official XBRL), 27 May 2026 — Open filing ↗
- Financial Results (official XBRL), 26 May 2026 — Open filing ↗
- Financial Results (official XBRL), 24 May 2026 — Open filing ↗
- Financial Results (official XBRL), 12 May 2026 — Open filing ↗
- Financial Results (official XBRL), 5 May 2026 — Open filing ↗
- Financial Results (official XBRL), 13 Aug 2025 — Open filing ↗
- Financial Results (official XBRL), 11 Aug 2025 — Open filing ↗
- Financial Results (official XBRL), 9 Aug 2025 — Open filing ↗
- Financial Results (official XBRL), 4 Aug 2025 — Open filing ↗
- Financial Results (official XBRL), 28 Jul 2025 — Open filing ↗
- Financial Results (official XBRL), 30 May 2025 — Open filing ↗
- Financial Results (official XBRL), 28 May 2025 — Open filing ↗
- Financial Results (official XBRL), 25 May 2025 — Open filing ↗
- Financial Results (official XBRL), 15 May 2025 — Open filing ↗
- Financial Results (official XBRL), 30 Apr 2025 — Open filing ↗